Serotonin syndrome by drug interactions with linezolid: clues from pharmacovigilance-pharmacokinetic/pharmacodynamic analysis

PURPOSE: To characterize the post-marketing reporting of serotonin syndrome (SS) due to drug-drug interactions (DDIs) with linezolid and investigate the relationship with pharmacokinetic/pharmacodynamic (PK/PD) properties of serotonergic agents. METHODS: We queried the worldwide FDA Adverse Event Re...

Descripción completa

Detalles Bibliográficos
Autores principales: Gatti, Milo, Raschi, Emanuel, De Ponti, Fabrizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Pharmacoepidemiology and Prescription
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803711/
https://www.ncbi.nlm.nih.gov/pubmed/32901348
http://dx.doi.org/10.1007/s00228-020-02990-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803711/
https://www.ncbi.nlm.nih.gov/pubmed/32901348
http://dx.doi.org/10.1007/s00228-020-02990-1

Ejemplares similares